Back
Nemak SAB de CV Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
45
NMAKF
Nemak SAB de CV
Last Price:
0.1600
Seasonality Move:
0.38%
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
31.81
Seasonality Move:
0.54%
Sell
45
Nemak SAB de CV (NMAKF)
is a Sell
Is Nemak SAB de CV a Buy, Sell or Hold?
- The current Nemak SAB de CV [NMAKF] share price is $0.1620. The Score for NMAKF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NMAKF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $31.91. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NMAKF Stock Price Chart
What is Nemak SAB de CV's stock price today?
-
The Nemak SAB de CV share price today is $0.1620
The current trend is relatively stagnant and NMAKF is experiencing slight buying pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $31.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
NMAKF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 49.97 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.1501 - 0.1701) | Buy |
| Bollinger Bands (100): | (0.1584 - 0.2184) | Sell |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.64 | Buy |
| Relative Strength Index (14 RSI): | 83.82 | Buy |
| Chaikin Money Flow: | -14813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.72 - 25.2) | Buy |
| Bollinger Bands (100): | (17.96 - 22.88) | Buy |
NMAKF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.16 | Buy |
| 20-day SMA: | 0.16 | Buy |
| 50-day SMA: | 0.16 | Sell |
| 200-day SMA: | 0.2 | Sell |
| 8-day EMA: | 0.16 | Buy |
| 20-day EMA: | 0.16 | Buy |
| 50-day EMA: | 0.17 | Sell |
| 200-day EMA: | 0.2 | Sell |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.62 | Buy |
| 20-day SMA: | 21.6 | Buy |
| 50-day SMA: | 20.76 | Buy |
| 200-day SMA: | 15.19 | Buy |
| 8-day EMA: | 26.93 | Buy |
| 20-day EMA: | 23.33 | Buy |
| 50-day EMA: | 21.23 | Buy |
| 200-day EMA: | 16.56 | Buy |
Nemak SAB de CV Earnings Growth & NMAKF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
Nemak SAB de CV Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||